This inventor holds 9 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2025
Title: **Innovator Dragutin Knezic: Pioneering Solutions for Cystic Fibrosis**
Introduction
Dragutin Knezic is a prominent inventor based in Watertown, Massachusetts, recognized for his significant contributions to pharmaceutical innovations. With an impressive portfolio of nine patents, Knezic demonstrates a commitment to advancing medical treatments, particularly for cystic fibrosis.
Latest Patents
Among Knezic's latest inventions is a pharmaceutical composition designed for treating cystic fibrosis. This innovative composition includes a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide. His work encompasses formulations of solid dispersions into powders, granules, and mini-tablets, alongside various methods for processing these formulations. Another notable patent features compositions comprising multiple therapeutic agents, where one agent enhances the properties of others. This approach includes agents aimed at treating cystic fibrosis transmembrane conductance regulator-mediated diseases, showcasing Knezic's dedication to improving treatment efficacy.
Career Highlights
Knezic is currently affiliated with Vertex Pharmaceuticals, a leading biopharmaceutical company that specializes in developing medicines for serious diseases. His role at Vertex allows him to focus on innovative research and development, leading to transformative solutions for patients suffering from cystic fibrosis.
Collaborations
Throughout his career, Knezic has collaborated with talented individuals such as Eleni Dokou and Shahla Jamzad, further enriching the innovative environment at Vertex Pharmaceuticals. These partnerships not only foster a creative atmosphere but also enhance the development of groundbreaking treatments.
Conclusion
Dragutin Knezic's contributions to the pharmaceutical field, particularly in the treatment of cystic fibrosis, reflect his innovative spirit and dedication to advancing medical science. His work continues to inspire and lead the way for future inventions that aim to improve the quality of life for patients worldwide. Knezic exemplifies the impact that focused research and collaboration can have in achieving significant breakthroughs in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile